Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasm Metastasis 2Hematologic Neoplasms 2Fallopian Tube Neoplasms 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Malignant Solid Neoplasm 1Carcinoma in Situ 1Brenner Tumor 1

Interventions

Paclitaxel 11Carboplatin 7Cisplatin 5Taxes 4paclitaxel poliglumex 2Topotecan 2Etoposide 2elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Watchful Waiting 1VTX-2337 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Observation 1Mitoxantrone 1Methods 1Mental Status and Dementia Tests 1Granisetron 1Educational Status 1Early Intervention, Educational 1Dexamethasone 1Cyclophosphamide 1Counseling 1Chemotherapy, Adjuvant 1Calcium Dobesilate 1Aprepitant 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Brenner Tumor × Methods × Clear all
NCT00719303 2018-02-19

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

GOG Foundation

Phase 3 Unknown
1,070 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡